Jeong A Kim | Medicine and Dentistry | Best Researcher Award

Published on 25/02/202525/02/2025 by Book of Award

Prof. Jeong A Kim | Medicine and Dentistry | Best Researcher Award

St. Vincent Hospital, The Catholic University of Korea | South Korea

Author Profile

Early Academic Pursuits ✨

Prof. Jeong A Kim embarked on an illustrious academic journey in the field of medicine, laying a solid foundation at the Catholic University Medical College. She completed her premedical course in 1986, followed by earning her Doctor of Medicine degree in 1990. Her passion for internal medicine and hematology led her to pursue advanced studies at The Catholic University of Korea, where she obtained a Master’s degree in 1998 and a Ph.D. in 2001. This strong academic background established her as a dedicated scholar committed to the advancement of medical sciences.

Professional Endeavors 🏥

Prof. Kim's professional career began with rigorous postdoctoral training. She completed her internship at St. Mary’s Hospital in 1991, followed by a residency in Internal Medicine at Catholic University Medical College until 1995. She further honed her expertise in hemato-oncology through a fellowship at Samsung Medical Center. Her international exposure expanded when she joined the Department of Microbiology and Immunology at IUPUI, USA, as a postdoctoral researcher. Her academic appointments at The Catholic University of Korea saw a steady rise, from Instructor in 1997 to Assistant Professor in 2001, Associate Professor in 2009, and finally attaining the prestigious title of Professor of Internal Medicine in 2014. In parallel, she has been a dedicated physician at St. Vincent Hospital since 1997 and has been leading the hematology and stem cell transplantation center since 2018.

Contributions and Research Focus 📝

Prof. Kim has made groundbreaking contributions in hematology and oncology, with a primary focus on stem cell transplantation, multiple myeloma, and lymphoma. Her extensive clinical trials and research studies have played a pivotal role in developing new treatment modalities for hematologic malignancies. Her work in targeted therapies, chemotherapy combinations, and immunotherapy has significantly improved patient outcomes and quality of life. She has been involved in more than 60 clinical trials, evaluating novel drug efficacy and safety, including studies on Zoledronic acid for multiple myeloma, targeted treatments like Dasatinib for leukemia, and the role of rituximab in lymphoma. Her research has also delved into prognostic factors, precision medicine, and innovative therapeutic strategies for refractory and relapsed hematologic diseases.

Accolades and Recognition 🏆

Prof. Kim's relentless pursuit of excellence has earned her recognition from esteemed medical institutions and societies. As a member of the Korean Association of Internal Medicine, the Korean Hematology Association, and the American Hematology Association, she has played an instrumental role in shaping global hematologic research. Her contributions have been acknowledged through numerous awards, invitations as a keynote speaker, and influential publications in high-impact medical journals.

Impact and Influence ✨

With a career spanning decades, Prof. Kim has mentored numerous young medical professionals, guiding them in clinical research and evidence-based medical practice. Her work has directly influenced hematologic treatment protocols in Korea and internationally. Her leadership in hematology and stem cell transplantation has set new benchmarks in patient care and innovative treatment approaches.

Legacy and Future Contributions 🌟

Prof. Jeong A Kim's legacy is deeply ingrained in the advancements of hematology and oncology. Her dedication to research, patient care, and education continues to inspire the next generation of medical professionals. Looking ahead, she remains committed to pioneering more targeted therapies, enhancing stem cell transplantation techniques, and improving long-term survival rates for hematologic malignancy patients. With ongoing research and collaborations, she is poised to make even greater strides in the field, leaving an indelible mark on medical science and patient care.

Publications

📄 The presence of clonal isotype switch after autologous stem cell transplantation as a prognostic biomarker for long-term survival in patients with multiple myeloma
Authors: H. Cho, J. Kim, Y. Park, Y. Kim, J. Kim, Jeong-ah
Journal: Leukemia Research
Year: 2025

📄 Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma
Authors: N.L. Bartlett, U.H. Hahn, W. Kim, F. Jie, J. Kim, Jeong-ah
Journal: Journal of Clinical Oncology
Year: 2025

📄 Early dose reduction of dasatinib does not compromise clinical outcomes in patients with chronic myeloid leukemia: A comparative analysis of two prospective trials
Authors: D. Shin, S. Park, E. Jang, W. Lee, D. Kim
Journal: Leukemia Research
Year: 2024

📄 Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study
Authors: H.Y. Yhim, Y. Park, J. Kim, Jeong-ah, D. Yang, J. Kwak
Journal: The Korean Journal of Internal Medicine
Year: 2024

Lucio Neto | Materials Science | Best Researcher Award

Published on 08/02/202508/02/2025 by Book of Award

Dr. Lucio Neto | Materials Science | Best Researcher Award

Federal University of Paraná (UFPR) | Brazil

Author Profile

Scopus

Orcid

Google Scholar

Early Academic Pursuits 📚🎓

Dr. Lucio Neto’s academic journey is a testament to his dedication to scientific excellence. He began his higher education at the University of Brasília (UnB), where he earned a degree in Biotechnology. His passion for cellular biology and biomaterials fueled his pursuit of advanced studies. Eager to deepen his expertise, he obtained both a Master’s and PhD in Pharmaceutical Sciences from the Federal University of Paraná (UFPR). His doctoral research focused on biopolymeric filaments, utilizing a carbohydrate-protein base to assess their physical properties and applications in cell cultures. This pioneering work set the stage for his contributions to tissue engineering and regenerative medicine.

Professional Endeavors 🔍🏗️

Currently, Dr. Neto serves as a Postdoctoral Researcher at the Polymer Science and Technology Laboratory of the State University of Campinas (Unicamp). His research delves into tissue regeneration, combining additive manufacturing with bioactive particles to develop innovative biomaterials. His professional career also includes a three-year tenure at the Molecular Pathology of Cancer (PMC) Group, where he specialized in bioprospecting and cytotoxic activity of anacardic acid derivatives in human oral cancer cells. Additionally, his work at the Nanobiotechnology Laboratory (Embrapa Genetic Resources and Biotechnology) led to groundbreaking advancements in magnetic iron oxide nanoparticle synthesis for 3D cellular cultures. Beyond research, Dr. Neto has enriched the academic community as a professor at Solução Diferencial in Brasília, shaping future scientists through his expertise in biotechnology and bioengineering.

Contributions and Research Focus 🔬🧬

Dr. Neto’s research spans multiple cutting-edge fields, including:

Biopolymers & 3D Bioprinting – Developing bioengineered materials for regenerative medicine.
Tissue Regeneration – Innovating biomaterials through additive manufacturing and bioactive compounds.
Nanobiotechnology – Synthesizing nanoparticles to enhance cellular interactions in tissue culture.
Cancer Research – Investigating novel compounds with potential therapeutic applications.

His proficiency with state-of-the-art bioprinting and 3D printing technologies has positioned him at the forefront of modern biomedical engineering.

Accolades and Recognition 🏆🎖️

Dr. Neto’s dedication has been acknowledged through numerous awards and accolades. His excellence in research earned him first-place honors in academic events and awards from the Brazilian Agricultural Research Corporation (EMBRAPA). Additionally, his contributions at UnB and UFPR were recognized with honorable mentions, further cementing his status as an outstanding scientist.

Impact and Influence 🌍✨

Through his extensive collaborations with multidisciplinary researchers, Dr. Neto has contributed to groundbreaking innovations in bioengineering. His work has been published in high-impact scientific journals, influencing research in nanobiotechnology, regenerative medicine, and pharmaceutical sciences. His active participation in scientific conferences, through oral presentations and poster sessions, has expanded the reach of his discoveries, inspiring both peers and aspiring researchers in the field.

Legacy and Future Contributions 🚀🔗

As a researcher, educator, and innovator, Dr. Lucio Neto’s contributions extend far beyond academia. His work in biopolymers and tissue regeneration continues to pave the way for new medical breakthroughs. His future endeavors promise further advancements in regenerative medicine, biofabrication, and nanotechnology, pushing the boundaries of scientific discovery.

Publications

📄Advancing Hydrogel-Based 3D Cell Culture Systems: Histological Image Analysis and AI-Driven Filament Characterization
- Authors: Lucio Assis Araujo Neto, Alessandra Maia Freire, Luciano Paulino Silva
- Journal: Biomedicines
- Year: 2025

📄Characterization of Hydrogel Filaments: Investigating Behavior, Mechanical Strength, and Degradation Over Time
- Authors: Lucio Assis Araujo Neto, Luciano Paulino Silva
- Journal: Polymer Bulletin
- Year: 2024

📄Influence of Biopolymer Composition and Crosslinking Agent Concentration on the Micro- and Nanomechanical Properties of Hydrogel-Based Filaments
- Authors: Lucio Assis Araujo Neto, Luciano Paulino Silva
- Journal: Journal of the Mechanical Behavior of Biomedical Materials
- Year: 2023

📄Magnetic Nanoparticles Coated with Carbohydrates for 3D Culture of Bacteria
- Authors: Lucio Assis Araujo Neto
- Journal: Materials Science and Engineering: C
- Year: 2020

📄Evaluation of Behavior, Growth, and Swarming Formation of Escherichia coli and Staphylococcus aureus in Culture Medium Modified with Silver Nanoparticles
- Authors: Lucio Assis Araujo Neto
- Journal: Microbial Pathogenesis
- Year: 2020

Bin Zheng | Biomedicine | Best Researcher Award

Published on 20/11/202420/11/2024 by Book of Award

Prof. Dr. Bin Zheng | Biomedicine | Best Researcher Award

Tianjin University | China

Author Profile

Scopus

Orcid

Early Academic Pursuits 🌱

Prof. Dr. Bin Zheng’s academic journey began with a solid foundation in medical engineering and translational medicine. He further honed his expertise as a postdoctoral fellow at the Caroline School of Medicine, Sweden, laying the groundwork for a prolific career. His early pursuits in biomaterials and nanotechnology provided a strong base for his subsequent innovations and contributions to biomedical sciences.

Professional Endeavors 🏢

As a professor at Tianjin University's Academy of Medical Engineering and Translational Medicine, Dr. Zheng has led numerous research projects, including 10 completed and 6 ongoing endeavors. With over 30 impactful SCI publications, his work has gained recognition on a global scale. His collaborations with leading companies have fostered breakthroughs in cellular manufacturing and delivery technologies, enhancing both academic and industrial applications.

Contributions and Research Focus 🔬

Dr. Zheng’s work spans a wide range of fields, including biomaterials, cancer research, cellular microbiology, immunity, and nanobiotechnology. He has developed innovative therapeutic agents, including a nebulizable anti-bacterial spray targeting exosomes and stem cell extracts. His patents—70 published and 14 in progress—reflect his commitment to bridging the gap between laboratory research and clinical application.

Accolades and Recognition 🏆

Dr. Zheng’s outstanding contributions have earned him numerous awards, such as the Excellent Doctoral Dissertation of Tianjin Municipality and the First Prize for Innovative Achievements from the China Industry-University-Research Cooperation Association. Under his mentorship, graduate students have garnered over 20 prestigious awards, solidifying his role as an influential academic leader.

Impact and Influence 🌍

His research has been clinically translated and widely reported by media outlets like Science and Technology Daily and Science Net. As an editorial board member of prestigious journals, Dr. Zheng also influences the direction of global biomedical research. His international collaborations and contributions to standards like the Belt and Road LSEA 0006-2022 standard underscore his global impact.

Legacy and Future Contributions 🌟

Prof. Dr. Bin Zheng’s legacy lies in his innovative methodologies and translational focus, which continue to inspire the next generation of researchers. With ongoing projects in cutting-edge fields like optogenetics and cellular precision manufacturing, his future contributions are set to redefine the boundaries of medical engineering and translational medicine.

Publications

📄 Microorganism microneedle micro-engine depth drug delivery
Author(s): Zheng, B., Li, Q., Fang, L., Cheng, S.-X., Zhang, X.
Journal: Nature Communications
Year: 2024

📄 Near-infrared remote triggering of bio-enzyme activation to control intestinal colonization by orally administered microorganisms
Author(s): Sun, W., Yun, F., Guo, Q., Zheng, B., Ruan, X.
Journal: Acta Biomaterialia
Year: 2024

📄 Surface nanocoating-based universal platform for programmed delivery of microorganisms in complicated digestive tract
Author(s): Du, Y., Guo, H.L., Su, X., Wang, T., Zheng, B.
Journal: Journal of Colloid and Interface Science
Year: 2024

📄 A self-assembling bioactive oligopeptide hydrogel for the treatment of edema following prepuce surgery
Author(s): Liu, J., Pei, Y., Huang, Y., Chen, L., Zhou, Y.
Journal: Journal of Materials Chemistry B
Year: 2024

📄 NIR-Remote Selectively Triggered Buprenorphine Hydrochloride Release from Microneedle Patches for the Treatment of Neuropathic Pain
Author(s): Han, H., Li, B., Yang, R., Bai, Y., Yu, Y.
Journal: ACS Biomaterials Science and Engineering
Year: 2024

Ylenia Della Rocca | Medicine and Dentistry | Best Researcher Award

Published on 20/09/202420/09/2024 by Book of Award

Dr. Ylenia Della Rocca | Medicine and Dentistry | Best Researcher Award

University of Chieti | Italy

Author Profile

Scopus

Orcid

🌱 Early Academic Pursuits

Dr. Ylenia Della Rocca’s academic journey began with exceptional achievements in biotechnology. In 2018, she earned her degree in Biotechnology with a perfect score of 110/110 cum laude from the University of L'Aquila. Her thesis, centered on "Hairy Cell Leukemia," set the stage for her future in oncohematological genetics. She continued to excel with a Master’s degree in Medical Biotechnology, again graduating with academic praise. Her research on the HLA-G 3' UTR region in kidney transplantation at the National Research Center solidified her expertise in medical biotechnology.

🏥 Professional Endeavors

Currently, Dr. Della Rocca serves as a Researcher Technologist and Subject Expert in Histology and Embryology at the University of Chieti. Her impressive academic trajectory culminated in a Ph.D. in "Innovative Technologies in Clinical Medicine & Dentistry" in 2024. As part of her doctoral research, she developed a new iPS cell line during her tenure at the University of Barcelona and Josep Carreras Leukaemia Research Institute. Beyond her role as a researcher, Dr. Della Rocca has been a prominent speaker at numerous international conferences, where her work has garnered significant recognition.

🔬 Contributions and Research Focus

Dr. Della Rocca’s research is at the forefront of biotechnology and regenerative medicine. Her completed and ongoing projects include the development of three-dimensional disease models, studies on tissue differentiation, and the establishment of new iPS cell lines. She has also been pivotal in creating innovative models for carcinogenesis research. Her current patent under review—"Pluripotent Stem Cells Induced by Autologous Gingival Stem Cells and Extracellular Vesicles: A Novel Approach for Cardiac Regeneration"—underscores her groundbreaking contributions to stem cell therapies and regenerative medicine.

🏆 Accolades and Recognition

Dr. Della Rocca’s research career has been marked by numerous accolades, including two prestigious awards for her scientific achievements. She has been a Guest Editor for special issues in renowned journals like the International Journal of Molecular Sciences and has served as a Review Editor for Frontiers in Genetics and Frontiers in Cell and Developmental Biology. Her citation index of 10 reflects the growing impact of her research in the scientific community.

🌍 Impact and Influence

Dr. Della Rocca’s work transcends academic research, as evidenced by her collaborations with top universities and research institutes worldwide, including the University of Barcelona, IRCCS Sicily, and the University of Montreal. She is an active member of the Italian Society of Anatomy and Histology and the Sigma Xi Scientific Research Honor Society. Dr. Della Rocca’s commitment to healthcare is further exemplified by her founding of Associazione Sorrisi in Ospedale (A.S.I.O.), a third-sector organization aimed at improving patient care in hospitals.

🔮 Legacy and Future Contributions

As a leader in the fields of stem cells, bioengineering, and regenerative medicine, Dr. Ylenia Della Rocca continues to push the boundaries of scientific knowledge. Her contributions to cell-free therapies and the development of three-dimensional models hold immense promise for future medical applications. With her ongoing work in stem cell regeneration and epigenetic research, Dr. Della Rocca is poised to shape the next frontier of clinical and research tools, leaving a lasting legacy in biotechnology.

Publications

📄 Autologous hGMSC-Derived iPS: A New Proposal for Tissue Regeneration
Authors: Ylenia Della Rocca, Francesca Diomede, Fanì Konstantinidou, Valentina Gatta, Liborio Stuppia, Umberto Benedetto, Marco Zimarino, Paola Lanuti, Oriana Trubiani, Jacopo Pizzicannella
Journal: International Journal of Molecular Sciences
Year: 2024

📄 Biological Effects of PMMA and Composite Resins on Human Gingival Fibroblasts: An In Vitro Comparative Study
Authors: Ylenia Della Rocca, Enrico Matteo Traini, Oriana Trubiani, Tonino Traini, Antonella Mazzone, Guya Diletta Marconi, Jacopo Pizzicannella, Francesca Diomede
Journal: International Journal of Molecular Sciences
Year: 2024

Fang Wang | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on 03/08/202403/08/2024 by Book of Award

Dr. Fang Wang | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Maastricht University | Netherlands

Author Profile

Scopus

Orcid

Early Academic Pursuits 📚

Dr. Fang Wang's academic journey began with a Bachelor’s degree in Pharmacology from Nanchang University, where she developed an oxidative stress model in LO2 cells to test stress amelioration compounds. She continued her studies with a Master's degree in Cell Biology at the same university, focusing on the role of progesterone adiponectin receptor 7 in reproduction and differences in protein post-translational modifications. Currently, she is pursuing a PhD in Cell Biology at Maastricht University, investigating substrate metabolism in diabetic cardiomyopathy and novel treatments using bioactive components from Traditional Chinese Medicine.

Professional Endeavors 🔬

With over seven years of experience, Dr. Wang has built a strong foundation in preclinical research, drug development, scientific communication, and project management. Her professional career includes internships at Shanghai ChemPartner Co., Ltd. and Jiangxi Zhby Biotech Co. Ltd., where she gained hands-on experience in molecular biology testing and research planning. Her current roles involve significant contributions to research in metabolic disorders and male infertility, with a focus on protein translocation and endosome pH regulation.

Contributions and Research Focus 🌟

Dr. Wang’s research primarily targets the intersection of metabolic disorders and drug development, specifically focusing on diabetic cardiomyopathy and the impact of Traditional Chinese Medicine on cardiac health. Her work includes investigating novel treatment strategies and exploring the mechanisms of substrate metabolism, protein translocation, and endosome pH regulation. Her expertise spans a wide range of molecular and cell biology techniques, including advanced imaging and bioinformatics.

Accolades and Recognition 🏆

Dr. Wang has made notable contributions to the field through her publications and presentations at various conferences. Her research on lipid-induced contractile dysfunction and diabetic cardiomyopathy has been recognized in leading journals and upcoming publications. Her work is highly regarded in the scientific community, reflecting her commitment to advancing healthcare solutions.

Impact and Influence 🌍

Dr. Wang's research has a profound impact on understanding and treating metabolic disorders, particularly in diabetic cardiomyopathy. Her innovative approaches and exploration of traditional medicine offer promising solutions for improving patient outcomes and advancing the field of metabolic disease research. Her contributions are shaping new therapeutic strategies and enhancing the quality of life for patients.

Legacy and Future Contributions 🚀

Dr. Wang's future endeavors are set to further explore and develop cutting-edge healthcare solutions. Her ongoing research aims to refine treatment strategies for metabolic disorders and improve the efficacy of drug development. By integrating advanced techniques and traditional medicine, she is poised to make significant strides in the field, contributing to a healthier future and advancing scientific knowledge.

Publications 📕

📝 Specific Compounds Derived from Traditional Chinese Medicine Ameliorate Lipid-Induced Contractile Dysfunction in Cardiomyocytes
- Authors: Fang Wang, Dietbert Neumann, Dimitrios Kapsokalyvas, Martijn Hoes, Francesco Schianchi, Jan Glatz, Miranda Nabben, Joost J. F. P. Luiken
- Journal: International Journal of Molecular Sciences
- Year: 2024

📝 Glycolysis-Mediated Activation of v-ATPase by Nicotinamide Mononucleotide Ameliorates Lipid-Induced Cardiomyopathy by Repressing the CD36-TLR4 Axis
- Authors: Shujin Wang, Han YinYing, Ruimin Liu, Hou M, Dietbert Neumann, Jun Zhang, Wang F, Yumeng Li, Zhao X, Francesco Schianchi et al.
- Journal: Circulation Research
- Year: 2024

📝 Progestin and adipoQ receptor 7 (PAQR7) mediate the anti-apoptotic effect of P4 on human granulosa cells and its deficiency reduces ovarian function in female mice
- Authors: Li J, Liu Y, He J, Wu Z, Wang F, Huang J, Zheng L, Luo T
- Journal: Journal of Ovarian Research
- Year: 2024

📝 CD36 as a target for metabolic modulation therapy in cardiac disease
- Authors: Glatz JFC, Wang F, Miranda Nabben, Luiken JJFP
- Journal: Expert Opinion on Therapeutic Targets
- Year: 2021

📝 Diet-induced obesity is associated with altered expression of sperm motility-related genes and testicular post-translational modifications in a mouse model
- Authors: Wang F, Chen H, Chen Y, Cheng Y, Li J, Zheng L, Zeng X, Luo T
- Journal: Theriogenology
- Year: 2020

Vijayalakshmi Venkatesan | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on 13/05/202413/05/2024 by Book of Award

Dr. Vijayalakshmi Venkatesan | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Regenerative Research Sciences Private Limited | India

Author profile

Scopus

Early Academic Pursuits

Dr. Vijayalakshmi Venkatesan began her academic journey with a B.Sc. in Botany, Zoology, and Chemistry, achieving First Class with Distinction. She pursued her passion further with an M.Sc. in Biochemistry, securing the second rank in the university. Her academic pursuit culminated in a Ph.D. in Biochemistry from the National Institute of Nutrition/Osmania University. Following this, she engaged in postdoctoral research at the Centre for Cellular and Molecular Biology.

Professional Endeavors

Dr. Vijayalakshmi Venkatesan's professional journey has been marked by significant roles in academia and research. She served as the Director-Grade Scientist and Head of Cell & Molecular Biology and Stem Cell Research at the National Institute of Nutrition, ICMR, Hyderabad. Currently, she holds the position of Director-Research at Movva Health Care LLP, RegenOrthoSport, where she continues to contribute to cutting-edge research in biochemistry and stem cell research.

Contributions and Research Focus

Her research focuses on regenerative medicine, particularly in addressing non-communicable diseases (NCDs) like diabetes, obesity, and knee osteoarthritis. Dr. Vijayalakshmi Venkatesan's work involves understanding the pathophysiology of these diseases at the cellular and molecular levels. She has made significant strides in the isolation, characterization, and therapeutic application of mesenchymal stem cells (MSCs) derived from various sources, including placenta and bone marrow. Additionally, her research explores the potential of nutraceuticals in managing these conditions, highlighting the beneficial effects of compounds like stigmasterol, gingerol, and shogaol.

Accolades and Recognition

Dr. Vijayalakshmi Venkatesan's contributions to the field have been recognized through numerous awards and honors. She has been felicitated with awards such as the Woman of Excellence Award, Venus International Award for Excellence in Biochemistry and Stem Cell Research, and the Dr. S.N. Acharya Felicitation Award. Her expertise has also earned her fellowship status in prestigious organizations like the National Academy of Medical Sciences and the Telangana Academy of Sciences.

Impact and Influence

Dr. Vijayalakshmi Venkatesan's research has left a significant impact on both academia and clinical practice. Her findings have been published extensively in peer-reviewed journals, with over 100 scientific articles and several book chapters to her credit. She has also been granted multiple patents for her innovative research in liver cell therapy and mesenchymal stem cell transplantation. Moreover, she actively participates in various professional societies and serves on the editorial boards of esteemed journals in the field.

Legacy and Future Contributions

Dr. Vijayalakshmi Venkatesan's legacy lies in her pioneering work at the intersection of biochemistry, genetics, and regenerative medicine. Her ongoing efforts in translational research aim to bridge the gap between laboratory discoveries and clinical applications, with a focus on improving healthcare outcomes for patients with metabolic disorders and musculoskeletal conditions. As she continues to lead research initiatives and mentor future scientists, her contributions are poised to shape the future of regenerative medicine and personalized healthcare.

Notable Publications

The role of Lp-PLA₂ and biochemistry parameters as potential biomarkers of coronary artery disease in Asian South-Indians: a case-control study 2017 (10)